Clinical Trial Update: Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating liraglutide (Saxenda) in adolescents with obesity after sleeve gastrectomy has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Obesity, Status Post Sleeve Gastrectomy | Phase 2 | Status: COMPLETED | Results posted: 2024-11-20